The development and implementation of pathological parameters and molecular testing impact prognosis of colorectal adenocarcinomaMidie Xu, Weiqi Sheng, Yaqi Li et al.|Journal of the National Cancer Center|2024Cited by 4
QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLCYaqi Li, Chao Shi, Cheng Zhang et al.|SSRN Electronic Journal|2020Cited by 3
Trends of Pathological Parameters and Molecular Testing of Colorectal Adenocarcinoma: A Retrospective Cohort Study on 21141 Patients Managed from 2008 to 2020Midie Xu, Weiqi Sheng, Dan Huang et al.|SSRN Electronic Journal|2023Cited by 0